Come up with a name for your new list and we'll add to it:
Agenovir was acquired by
Vir Biotechnology on May 09, 2018.
Agenovir is a player in the research and development of a novel class of human therapeutics to address diseases associated with or caused by latent or persistent viral reservoirs. The individuals affe…